X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (42) 42
female (33) 33
male (33) 33
aged (27) 27
pathology (25) 25
middle aged (24) 24
unclassifiable (23) 23
adult (22) 22
classification (17) 17
immunohistochemistry (17) 17
diagnosis (16) 16
diffuse large b-cell lymphoma (15) 15
myc (15) 15
prognosis (15) 15
lymphomas (14) 14
expression (13) 13
hematology (13) 13
oncology (13) 13
aged, 80 and over (12) 12
adolescent (11) 11
b-cell lymphoma (11) 11
bcl2 (11) 11
chemotherapy (11) 11
diagnosis, differential (11) 11
in situ hybridization, fluorescence (11) 11
lymphoma, b-cell - genetics (11) 11
lymphoma, b-cell - pathology (11) 11
lymphoma, large b-cell, diffuse - pathology (11) 11
burkitt lymphoma (10) 10
hemic and lymphatic diseases (10) 10
features (9) 9
immune system diseases (9) 9
lymphoma, large b-cell, diffuse - diagnosis (9) 9
lymphoma, large b-cell, diffuse - genetics (9) 9
survival (9) 9
analysis (8) 8
disease (7) 7
follicular lymphoma (7) 7
immunophenotyping (7) 7
leukemia (7) 7
lymphoma, b-cell - diagnosis (7) 7
respiratory system (7) 7
retrospective studies (7) 7
translocation, genetic (7) 7
tumors (7) 7
unclassifiable region (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
article (6) 6
b-cell lymphoma unclassifiable (6) 6
biomarkers, tumor - genetics (6) 6
burkitt lymphoma - genetics (6) 6
double-hit lymphoma (6) 6
gene rearrangement (6) 6
idiopathic pulmonary fibrosis (6) 6
neoplasm staging (6) 6
non-hodgkins-lymphoma (6) 6
pneumonia (6) 6
poor-prognosis (6) 6
proto-oncogene proteins c-myc - genetics (6) 6
rituximab plus cyclophosphamide (6) 6
unclassifiable b-cell lymphoma (6) 6
young adult (6) 6
biomarkers, tumor - metabolism (5) 5
biopsy (5) 5
burkitt lymphoma - pathology (5) 5
burkitt-lymphoma (5) 5
c-myc (5) 5
diffuse large b cell lymphoma (5) 5
disease progression (5) 5
gray zone lymphoma (5) 5
hodgkin disease - pathology (5) 5
idiopathic interstitial pneumonia (5) 5
idiopathic pulmonary-fibrosis (5) 5
interstitial lung disease (5) 5
myelodysplastic syndromes - diagnosis (5) 5
myeloproliferative neoplasms (5) 5
pathogenesis (5) 5
support vector machines (5) 5
treatment outcome (5) 5
unclassifiable interstitial pneumonia (5) 5
acute myeloid-leukemia (4) 4
b-cell lymphoma unclassifiable with features intermediate between dlbcl and bl (4) 4
bone marrow (4) 4
burkitt lymphoma - diagnosis (4) 4
cancer (4) 4
child (4) 4
children (4) 4
chronic myelomonocytic leukemia (4) 4
double hit lymphoma (4) 4
doxorubicin (4) 4
essential thrombocythemia (4) 4
fluorescence (4) 4
immunophenotype (4) 4
lung diseases (4) 4
lymphatic system (4) 4
lymphoma (4) 4
lymphoma, b-cell - therapy (4) 4
lymphoma, large b-cell, diffuse - metabolism (4) 4
medical laboratory technology (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (109) 109
Polish (3) 3
French (2) 2
German (2) 2
Chinese (1) 1
Japanese (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Japanese Journal of Gastroenterological Surgery, ISSN 0386-9768, 12/2013, Volume 46, Issue 12, pp. 945 - 951
Journal Article
Journal Article
Histopathology, ISSN 0309-0167, 11/2012, Volume 61, Issue 5, pp. 945 - 954
Journal Article
Journal Article
International Journal of Surgical Pathology, ISSN 1066-8969, 5/2018, Volume 26, Issue 3, pp. 266 - 270
CD20-negative diffuse large B-cell lymphomas (DLBCLs) constitute a rare and heterogeneous group of aggressive lymphomas. Known well-documented variants include... 
CD20 | CD20 negative | diffuse large B-cell lymphoma | HIV | unclassifiable | large B-cell lymphoma | SURGERY | PATHOLOGY
Journal Article
Information Sciences, ISSN 0020-0255, 06/2013, Volume 235, pp. 174 - 194
In this paper, a new model named Multiclass Support Vector Machines with Vector-Valued Decision (M-SVMs-VVD) or VVD is proposed. The basic idea is to separate... 
Support vector machine (SVM) | Feature space | Unclassifiable region (UR) | Multiclass classification | Hyperplane | CRITERIA | PATTERN-CLASSIFICATION | COMPUTER SCIENCE, INFORMATION SYSTEMS | SVMS | CLASSIFIERS | Computer science | Analysis | Algorithms
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2016, Volume 175, Issue 4, pp. 631 - 640
Rearrangement of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma ( DLBCL ) and B cell lymphoma unclassifiable ( BCLU ),... 
diffuse large B cell lymphoma | fluorescence | in situ | MYC | B cell lymphoma unclassifiable | hybridization | chemotherapy | fluorescence in situ hybridization | SURVIVAL | TRANSLOCATION | IMMUNOCHEMOTHERAPY | R-CHOP | CLASSIFICATION | TRANSPLANTATION | IMPACT | fluorescence insitu hybridization | BURKITT-LYMPHOMA | FEATURES INTERMEDIATE | HEMATOLOGY | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Humans | Lymphoma, B-Cell - diagnosis | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Genes, myc | Lymphoma, B-Cell - genetics | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, B-Cell - mortality | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Proportional Hazards Models | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Lymphoma, Large B-Cell, Diffuse - diagnosis | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Gene Rearrangement | Vincristine - therapeutic use | Biomarkers | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphomas | Gene amplification | B cell lymphoma | CHEMOTHERAPY | Gene rearrangement
Journal Article